# Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease

> **NCT00240409** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 208 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Bromocriptine

## Key facts

- **NCT ID:** NCT00240409
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2004-08
- **Final completion:** 2004-08
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2013-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240409, "Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00240409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*